PAR DRUGS AND CHEM LTD (PAR)

NSE: ₹86.71
Back to Home
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 22.93 25.89 24.00 22.82 22.61 34.66 21.38 22.33 26.05 28.66 29.34 19.61
YOY Revenue Growth % 3.87% 4.31% 4.65% -6.83% -1.44% 33.88% -10.91% -2.14% 15.22% -17.31% 37.22% -12.18%
Other Income 0.01 0.05 0.23 -0.05 0.07 1.02 0.27 0.79 1.84 0.48 1.33 0.36
Total Income 22.95 25.94 24.23 22.77 22.68 35.67 21.65 23.12 27.88 29.14 30.67 19.97
Total Expenses + 19.14 17.41 19.14 16.66 20.14 22.02 20.03 20.84 23.41 23.59 24.22 19.14
Cost of Materials Consumed 10.01 7.90 8.22 7.19 9.25 10.83 8.89 10.43 11.16 10.54 12.12 8.85
Employee Benefit Expense 1.12 1.17 1.43 1.78 1.26 1.36 1.32 1.91 1.42 1.35 1.41 1.94
Other Expenses 8.01 8.35 9.48 7.69 9.62 9.83 9.82 8.21 9.73 10.51 9.47 7.33
Operating Profit 3.79 8.47 4.86 6.16 2.47 12.63 1.35 1.49 2.64 5.07 5.12 0.47
OPM % 16.5% 32.7% 20.3% 27% 10.9% 36.5% 6.3% 6.7% 10.1% 17.7% 17.4% 2.4%
Profit Before Tax + 3.30 6.54 4.57 5.11 3.39 11.49 0.77 2.28 4.48 5.55 6.44 0.83
Tax Expense 0.83 1.65 1.15 1.39 0.85 2.89 0.19 0.63 1.15 1.42 1.64 -0.02
Tax % 25.2% 25.2% 25.2% 27.2% 25.2% 25.2% 25.2% 27.5% 25.7% 25.6% 25.5% -2.7%
Profit After Tax 2.47 4.89 3.42 3.72 2.53 8.60 0.58 1.65 3.33 4.13 4.80 0.85
EPS (Basic) 2.01 3.97 2.78 3.02 2.06 6.99 0.47 1.34 2.70 3.36 3.90 0.69

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 100.97 95.64 95.75 75.07
YOY Revenue Growth % 5.58% -0.11% 27.54% -
Other Income 2.15 0.24 0.24 0.18
Total Income 103.12 95.88 95.99 75.26
Total Expenses + 85.20 72.35 78.24 59.61
Cost of Materials Consumed 39.41 33.32 41.03 29.61
Employee Benefit Expense 5.85 5.50 4.89 4.10
Other Expenses 37.49 33.53 32.33 25.90
Operating Profit 15.77 23.29 17.51 15.47
OPM % 15.6% 24.4% 18.3% 20.6%
Profit Before Exceptional 17.92 19.52 15.08 12.70
Exceptional Items 0.00 0.00 0.00 0.00
Profit Before Tax + 17.92 19.52 15.08 12.70
Tax Expense 4.57 5.02 3.75 3.49
Tax % 25.5% 25.7% 24.8% 27.5%
Profit After Tax 13.36 14.50 11.33 9.22
EPS (Basic) 10.86 11.78 9.21 7.49

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 64.53 41.99 39.43 0.00
Property, Plant & Equipment 38.91 41.31 38.45 0.00
Capital Work in Progress 0.00 0.03 0.25 0.00
Non-Current Investments 25.07 0.01 0.01 0.00
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00
Current Assets + 54.86 59.62 49.44 0.00
Inventories 6.11 4.18 5.38 0.00
Trade Receivables 16.71 13.71 16.97 0.00
Cash and Cash Equivalents 27.58 36.65 22.24 0.00
Current Investments 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00
Equity Share Capital 12.30 12.30 12.30 0.00
Other Equity 86.67 73.33 58.93 0.00
Non-Current Liabilities 3.85 3.54 3.64 0.00
Current Liabilities 16.57 12.44 13.99 0.00
Total Liabilities 20.42 15.98 17.63 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 16.16 20.25 13.38 7.62
Cash from Investing Activities -25.24 -5.84 -7.34 -3.02
Cash from Financing Activities 0.00 0.00 0.00 -9.55
Net Increase/Decrease in Cash -9.08 14.41 6.04 -4.96